Concepedia

Kevin J. Lynch

KJ

Statistics

Publications

28

Citations

3.2K

H-Index

22

Active since

1990

Affiliations

Abbott Fund(Current)

Abbott (United Kingdom)

Abbott (United States)

Yale University

University of Arizona

Kevin J. Lynch is an author at Abbott Fund specializing in pharmacology, medicine, and life sciences.

Publications per year

1990–2017

28

Publications

28

A novel endothelial-derived lipase that modulates HDL metabolism

Michael Jaye, Kevin J. Lynch, John A. Krawiec et al. · Nature Genetics · 1999 · 499 citations

, , +14

A-317491, a novel potent and selective non-nucleotide antagonist of P2X <sub>3</sub> and P2X <sub>2/3</sub> receptors, reduces chronic inflammatory and neuropathic pain in the rat

Michael F. Jarvis, Edward C. Burgard, Steve McGaraughty et al. · Proceedings of the National Academy of Sciences · 2002 · 466 citations

, , +17

Pharmacological characterization of recombinant human and rat P2X receptor subtypes

Bruce R. Bianchi, Kevin J. Lynch, Edward Touma et al. · European Journal of Pharmacology · 1999 · 337 citations

, , +10

Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats

Prisca Honoré, Karen Kage, Joseph P. Mikusa et al. · Pain · 2002 · 236 citations

, , +17

Automatic construction of networks of concepts characterizing document databases

Hao Chen, Kevin J. Lynch · IEEE Transactions on Systems Man and Cybernetics · 1992 · 221 citations

, , +17

1–5 of 28